← Eichor
Condition: Secondary Malignant Neoplasm Of Prostate Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Secondary Malignant Neoplasm Of Prostate

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

ARCTIC: Liquid Biomarkers in the Prospective Androgen Receptor Signaling Inhibitors (ARSI) Resistance Clinical Trials
Phase N/A · 3 location(s) · Duke University · NCT06141993Study of SYN818 for the Treatment of Advanced or Metastatic Solid Tumors
Phase 1 · 2 location(s) · Hangzhou SynRx Therapeutics Biomedical Technology Co., Ltd · NCT06666270A Clinical Study of Ifinatamab Deruxtecan Based Treatment Combinations or as Monotherapy to Treat Metastatic Castrate Re
Phase 1/Phase 2 · 82 location(s) · Merck Sharp & Dohme LLC · NCT06863272Different Fractionation Schedules of Radiotherapy to the Primary Tumour in Metastatic Hormone Sensitive Prostate Cancer
NA · 1 location(s) · Umeå University · NCT04612907Imaging of Solid Tumors Using 18F-TRX
Phase 1 · 1 location(s) · Rahul Aggarwal · NCT06942104Advanced Radiotherapy (ART) in Prostate Cancer (PROST-ART)
Phase N/A · 1 location(s) · IRCCS San Raffaele · NCT06546267Observation Study to Evaluate the Efficacy and Safety of Ifosfamide/Mesna in Patients With Metastatic Castration-resista
Phase N/A · 1 location(s) · Yonsei University · NCT06236789Access to Genetic Testing in Underserved Patients With Cancer
NA · 2 location(s) · University of Southern California · NCT06422455SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Phase N/A · 68 location(s) · Massive Bio, Inc. · NCT03452774Cryoablation Combined With Stereotactic Body Radiation Therapy for the Treatment of Painful Bone Metastases, the CROME T
NA · 1 location(s) · M.D. Anderson Cancer Center · NCT04693377The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study
Phase N/A · 18 location(s) · UMC Utrecht · NCT04075305A Phase 1b/2 Study of the Safety and Efficacy of the Monoclonal Antibody OM-RCA-01 in Patients With Metastatic Tumors Ex
Phase 1/Phase 2 · 5 location(s) · Kidney Cancer Research Bureau · NCT07292168A Study of NX-1607 in Adults With Advanced Malignancies
Phase 1 · 17 location(s) · Nurix Therapeutics, Inc. · NCT05107674A Study of LY4257496 in Participants With Cancer (OMNIRAY)
Phase 1 · 31 location(s) · Eli Lilly and Company · NCT07114601Collection and Measurement of Biomarkers in Prostate Cancer Radiotherapy Patients
Phase N/A · 1 location(s) · University of Miami · NCT02997709Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid Tumors
Phase 1 · 18 location(s) · MOMA Therapeutics · NCT06545942Cancer Experience Registry (CER) for Cancer Patients and Caregivers
Phase N/A · 1 location(s) · Cancer Support Community, Research and Training Institute, P · NCT02333604Comparison of Different Methods of CAPTure of Circulating Tumour Cells (CTC) in Patients With Metastatic Breast or Prost
NA · 1 location(s) · Institut Claudius Regaud · NCT06904625Consolidative Prostate Radiotherapy in Metastatic Prostate Cancer
Phase 2 · 1 location(s) · University Health Network, Toronto · NCT05656794Social, Structural, and Lifestyle Drivers of Prostate Cancer Disparities
Phase N/A · 1 location(s) · University of California, San Francisco · NCT07690579Ivonescimab in the Treatment of Multiple Advanced Tumors
Phase 2 · 1 location(s) · Fudan University · NCT06683846Evaluating Dose Timing (Morning vs Evening) of Endocrine-based Therapies in Metastatic Breast and Prostate Cancers
Phase 4 · 3 location(s) · Ottawa Hospital Research Institute · NCT07252726The Impact of Radiotherapy on Oligometastatic Cancer
Phase N/A · 21 location(s) · Institut Investigacio Sanitaria Pere Virgili · NCT05933876FOG-001 in Locally Advanced or Metastatic Solid Tumors
Phase 1/Phase 2 · 33 location(s) · Parabilis Medicines, Inc. · NCT05919264A Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate Cancer
Phase 1 · 25 location(s) · Astellas Pharma Global Development, Inc. · NCT04729114Biomarker-Guided Allogeneic Single-Target or Dual-Target CAR-NK Cell Therapy for Advanced Solid Tumors
Phase 1/Phase 2 · 1 location(s) · Essen Biotech · NCT07410494Evaluation of Clinical Outcomes of Chemotherapy or Androgen-receptor Targeting Agent (Alone or Combined) or Radiotherapy
Phase N/A · 3 location(s) · Santa Chiara Hospital · NCT06473259Low to Moderate Load Power Training for Men With Metastatic Prostate Cancer.
NA · 1 location(s) · University of Alicante · NCT07572760SL-28 for Advanced Solid Tumours
Phase 1/Phase 2 · 1 location(s) · Second Life Therapeutics · NCT07341737A Phase 1 Study of BPX-601 CAR T-Cell Therapy in Adult Participants With Prostate Cancer That Has Returned, is Resistant
Phase 1 · 1 location(s) · Regeneron Pharmaceuticals · NCT07543055
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.